Search Results
Found 1 results
510(k) Data Aggregation
(79 days)
The VIATORR® Endoprosthesis is indicated for the treatment of tracheobronchial strictures produced by malignant neoplasms.
The VIATORR Endoprosthesis is a self-expanding implantable endoprosthesis that is compressed and secured on the distal end of a catheter delivery system. The catheter delivery system provides a means for implanting the endoprosthesis at a target location within the tracheobronchial tract. The endoprosthesis consists of a fluoropolymeric tube with a nitinol structure located over its external surface and radiopaque markers. The catheter delivery system is configured with radiopaque markers and is designed for use with guidewires.
The provided document is a 510(k) premarket notification for the VIATORR® Endoprosthesis, a tracheal prosthesis. It does not contain information about acceptance criteria or a study demonstrating the device meets such criteria. The letter confirms substantial equivalence to predicate devices based on composition, design, intended use, and performance attributes, but no specific performance metrics, study designs, or ground truth establishment methods are detailed.
Therefore, I cannot provide the requested information from this document.
Ask a specific question about this device
Page 1 of 1